INTLOOP Inc. Logo

INTLOOP Inc.

Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.

9556 | T

Overview

Corporate Details

ISIN(s):
JP3153180009
LEI:
Country:
Japan
Address:
港区赤坂二丁目4番6号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

INTLOOP Inc. is a business creation-type consulting firm that provides comprehensive solutions for corporate transformation and management challenges. The company's operations are centered on a synergistic model that integrates consulting with several key business lines. Core offerings include PMO Solutions, providing project and resource management supported by a network of approximately 6,000 PMO specialists, and end-to-end Technology Solutions that span from strategic planning to system development. A primary differentiator is its Professional HR Solutions division, which operates one of Japan's largest talent platforms, connecting clients with over 49,000 registered freelance professionals. The company also offers recruitment support for consultants and engineers and manages various web-based matching platforms. This integrated approach allows INTLOOP to deliver tailored human capital and technology resources to drive project success for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 07:55
Registration Form
確認書
Japanese 8.8 KB
2025-10-27 07:51
Registration Form
有価証券報告書-第21期(2024/08/01-2025/07/31)
Japanese 2.1 MB
2025-07-04 10:03
Regulatory News Service
臨時報告書
Japanese 29.4 KB
2025-03-14 03:40
Interim Report
確認書
Japanese 8.7 KB
2025-03-14 03:37
Interim Report
半期報告書-第21期(2024/08/01-2025/07/31)
Japanese 201.0 KB
2025-02-10 07:48
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-10-31 07:12
Governance Information
内部統制報告書-第20期(2023/08/01-2024/07/31)
Japanese 23.0 KB
2024-10-31 07:09
Registration Form
確認書
Japanese 8.6 KB
2024-10-31 07:05
Registration Form
有価証券報告書-第20期(2023/08/01-2024/07/31)
Japanese 1.8 MB
2024-10-29 08:41
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2024-10-07 10:06
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-06-14 08:08
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-06-14 08:06
Quarterly Report
四半期報告書-第20期第3四半期(2024/02/01-2024/04/30)
Japanese 166.1 KB
2024-03-14 07:09
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-03-14 07:07
Quarterly Report
四半期報告書-第20期第2四半期(2023/11/01-2024/01/31)
Japanese 203.4 KB

Automate Your Workflow. Get a real-time feed of all INTLOOP Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INTLOOP Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INTLOOP Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA

Talk to a Data Expert

Have a question? We'll get back to you promptly.